全文获取类型
收费全文 | 8644篇 |
免费 | 652篇 |
国内免费 | 30篇 |
专业分类
耳鼻咽喉 | 63篇 |
儿科学 | 273篇 |
妇产科学 | 211篇 |
基础医学 | 1321篇 |
口腔科学 | 263篇 |
临床医学 | 718篇 |
内科学 | 2130篇 |
皮肤病学 | 298篇 |
神经病学 | 837篇 |
特种医学 | 139篇 |
外科学 | 710篇 |
综合类 | 54篇 |
预防医学 | 790篇 |
眼科学 | 191篇 |
药学 | 571篇 |
中国医学 | 49篇 |
肿瘤学 | 708篇 |
出版年
2023年 | 66篇 |
2022年 | 141篇 |
2021年 | 258篇 |
2020年 | 152篇 |
2019年 | 262篇 |
2018年 | 270篇 |
2017年 | 209篇 |
2016年 | 237篇 |
2015年 | 266篇 |
2014年 | 375篇 |
2013年 | 401篇 |
2012年 | 665篇 |
2011年 | 647篇 |
2010年 | 372篇 |
2009年 | 315篇 |
2008年 | 524篇 |
2007年 | 488篇 |
2006年 | 479篇 |
2005年 | 482篇 |
2004年 | 425篇 |
2003年 | 420篇 |
2002年 | 400篇 |
2001年 | 134篇 |
2000年 | 161篇 |
1999年 | 134篇 |
1998年 | 74篇 |
1997年 | 66篇 |
1996年 | 49篇 |
1995年 | 47篇 |
1994年 | 29篇 |
1993年 | 38篇 |
1992年 | 92篇 |
1991年 | 75篇 |
1990年 | 58篇 |
1989年 | 58篇 |
1988年 | 48篇 |
1987年 | 42篇 |
1986年 | 53篇 |
1985年 | 39篇 |
1984年 | 28篇 |
1983年 | 23篇 |
1982年 | 22篇 |
1980年 | 12篇 |
1979年 | 16篇 |
1978年 | 15篇 |
1976年 | 14篇 |
1971年 | 12篇 |
1970年 | 17篇 |
1967年 | 13篇 |
1966年 | 13篇 |
排序方式: 共有9326条查询结果,搜索用时 8 毫秒
1.
Adjuvant irradiation is the standard treatment after breast conservative surgery. Normofractionated regimen with an overall treatment time of 5 to 6 weeks is often considered as a limiting factor for irradiation compliance. In order to answer this issue, moderate and more recently extreme hypofractionated protocols appeared. We report here oncological outcomes and toxicity of hypofractionated breast irradiation. After defining the frame of moderate and extreme hypofractionated breast irradiations based on overall treatment time, patient selection criteria were listed. According to their levels of proof, the results of moderate and extreme hypofractionated breast irradiation were analysed. Overall treatment time for moderate hypofractionated breast irradiation ranged from 3 to 4 weeks, while for extreme hypofractionated breast irradiation, it was less than 1 week. For moderate hypofractionated breast irradiation, whole breast irradiation was currently performed with or without lymph node irradiation. Moderate hypofractionated breast irradiation has proven to be as safe and as efficient as normofractionated breast irradiation with level IA evidence. For extreme hypofractionated breast irradiation, phase III randomized trials confirmed that accelerated partial breast irradiation was non-inferior in terms of local control compared to normofractionated whole breast irradiation (with external beam radiation therapy and multicatheter brachytherapy), with similar acute and late toxicity. While the use of intraoperative breast irradiation remains under debate, new very accelerated partial breast irradiation (overall treatment time not exceeding 2 days) protocols emerged with encouraging results. Accelerated partial breast irradiation is warranted for extreme hypofractionated breast irradiation and is indicated for low-risk breast cancers. Moderate and extreme hypofractionated breast irradiation regimens are validated and can be routinely proposed according to patient selection criteria. 相似文献
2.
3.
4.
Maria Gonzalez-Cao Cristina Carrera Juan Francisco Rodriguez Moreno Pedro Rodríguez-Jiménez Mónica Antoñanzas Basa Rosa Feltes Ochoa Teresa Puertolas Eva Muñoz-Couselo José Luis Manzano Ivan Marquez-Rodas Juan Martín-Liberal Ainara Soria Pilar Lopez Criado Almudena Garcia-Castaño Aram Boada Pablo Ayala de Miguel Susana Puig Guillermo Crespo Alfonso Berrocal 《Journal of the American Academy of Dermatology》2021,84(5):1412-1415
5.
6.
7.
Alexander Stoff MD ; Angel A. Rivera PhD ; N. S. Banerjee PhD ; J. Michael Mathis PhD ; Antonio Espinosa-de-los-Monteros MD ; Long P. Le PhD ; Jorge I. De la Torre MD ; Luis O. Vasconez MD ; Thomas R. Broker PhD ; Dirk F. Richter MD ; Mariam A. Stoff-Khalili MD ; David T. Curiel MD PhD 《Wound repair and regeneration》2006,14(5):608-617
Genetically modified keratinocytes and fibroblasts are suitable for delivery of therapeutic genes capable of modifying the wound healing process. However, efficient gene delivery is a prerequisite for successful gene therapy of wounds. Whereas adenoviral vectors (Ads) exhibit superior levels of in vivo gene transfer, their transductional efficiency to cells resident within wounds may nonetheless be suboptimal, due to deficiency of the primary adenovirus receptor, coxsackie-adenovirus receptor (CAR). We explored CAR-independent transduction to fibroblasts and keratinocytes using a panel of CAR-independent fiber-modified Ads to determine enhancement of infectivity. These fiber-modified adenoviral vectors included Ad 3 knob (Ad5/3), canine Ad serotype 2 knob (Ad5CAV-2), RGD (Ad5.RGD), polylysine (Ad5.pK7), or both RGD and polylysine (Ad5.RGD.pK7). To evaluate whether transduction efficiencies of the fiber-modified adenoviral vectors correlated with the expression of their putative receptors on keratinocytes and fibroblasts, we analyzed the mRNA levels of CAR, alpha upsilon integrin, syndecan-1, and glypican-1 using quantitative polymerase chain reaction. Analysis of luciferase and green fluorescent protein transgene expression showed superior transduction efficiency of Ad5.pK7 in keratinocytes and Ad5.RGD.pK7 in fibroblasts. mRNA expression of alpha upsilon integrin, syndecan-1 and glypican-1 was significantly higher in primary fibroblasts than CAR. In keratinocytes, syndecan-1 expression was significantly higher than all the other receptors tested. Significant infectivity enhancement was achieved in keratinocytes and fibroblasts using fiber-modified adenoviral vectors. These strategies to enhance infectivity may help to achieve higher clinical efficacy of wound gene therapy. 相似文献
8.
9.
A new range of stand magnifiers has been released by the COIL company in the United Kingdom. Examination of these magnifiers reveals that they fail to deliver the rated magnifications labelled prominently on the appliances, as a result of the manufacturer's conformance with the requirements of the German DIN standard and the use of back vertex power (F'v) rather than equivalent dioptric power (Fm) of the magnifier. In this study we provide information on the optometric parameters of these new stand magnifiers that will assist the more accurate specification of improvements in vision expected from their use. 相似文献
10.
Antonio Rivera Antonio Yáñez Gloria León-Tello Constantino Gil Silvia Giono Eduardo Barba Lilia Cedillo 《BMC musculoskeletal disorders》2002,3(1):15-7